Sonoma Pharmaceuticals, Inc. SNOA US Equity
$1.31
-0.02 (-1.50%)
USD · as of 2026-08-28 · marketstack
Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), an SEC filer in Surgical & Medical Instruments & Apparatus, closed at $1.31, -1.5%, on 2026-08-28, with a market cap of $6M as of 2026-08-27, a return on equity of -84.6%, a net margin of -16.3% and 3-year sales growth of 13.7%. Institutional ownership, earnings history and filed financials are on the tabs below.
Short interest· FINRA consolidated · settlement 2026-08-14
6 settlement cycles| Shares short | 201K |
| % of shares out | 4.2% |
| Days to cover | 1.0 |
| Δ vs 2026-07-31 | +2279.8% |
bars = shares short · line = days to cover (own scale)
FINRA Rule 4560 · twice monthly, published ~a week later.
Output of a disclosed model — assumptions may be wrong. Research, not investment advice. See the Disclaimer.